Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease

Author： Lawrance Ian Craig  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.7, 2012-07, pp. : 975-984

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mucosal T Cell Proliferation and Apoptosis in Inflammatory Bowel Disease

By  

Current Drug Targets, Vol. 9, Iss. 5, 2008-05 ,pp. : 381-387

Bentham Science Publishers

Access to resources Recommend Favorite

Role of probiotics in inflammatory bowel disease and intestinal infections

By Campieri M   Venturi A   Gionchetti P   Rizzello F   Amadini C   Palmonari V   Romagnoli R   Simone C De  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1277-1283

Informa Healthcare

Access to resources Recommend Favorite

Modification of Intestinal Flora in the Treatment of Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 9, Iss. 4, 2003-02 ,pp. : 333-346

Bentham Science Publishers

Access to resources Recommend Favorite

Pathways of Inflammatory Activation in Alzheimer's Disease: Potential Targets for Disease Modifying Drugs

By  

Current Medicinal Chemistry, Vol. 9, Iss. 1, 2002-01 ,pp. : 83-88

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the management of inflammatory bowel disease

By Irving Peter M  

Clinical Medicine, Vol. 9, Iss. 6, 2009-12 ,pp. : 605-608

Royal College Of Physicians

Access to resources Recommend Favorite